Michael Wright, PA-C
NPI 1083016455 · Psychiatric/Mental Health Nurse Practitioner · Scottsdale, AZ
Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1083016455
- Entity type
- Individual
- Primary specialty
- Psychiatric/Mental Health Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- PA-C
- Sex
- Male
- Sole proprietor
- No
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
- Mental Health Counselor101YM0800X
Behavioral Health & Social Service Providers
- Medical Physician Assistant363AM0700X
Physician Assistants & Advanced Practice Nursing Providers
- Professional Counselor101YP2500X
Behavioral Health & Social Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
11 yrs in NPPES registry
- Profile completeness33% of score
83% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Buspirone Hcl | 40 | 13 |
| Lamotrigine | 38 | — |
| Trazodone Hcl | 24 | — |
| Dextroamphetamine/Amphetaminebrand: Dextroamphetamine-Amphet Er | 21 | — |
| Fluoxetine Hcl | 20 | — |
| Escitalopram Oxalate | 19 | — |
| Bupropion Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$100 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-09-17
- Last updated
- 2026-06-03
- Certified
- 2026-06-03
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.